Oral Misoprostol Solution for Labor Induction

Evidence-Based Dosing Recommendations

The American Academy of Family Physicians recommends using 20-25 µg oral misoprostol solution every 2-6 hours as the preferred starting dose for labor induction, which results in fewer cesarean sections and lower rates of uterine hyperstimulation 1
The optimal oral regimen is 20-25 µg every 2-6 hours, with lower dosages (25 µg every 3-6 hours) effective for cervical ripening and labor induction, while the 50 µg dose every 6 hours may be appropriate in some situations but carries increased risk of complications including uterine hyperstimulation 1

The American College of Obstetricians and Gynecologists advises avoiding misoprostol entirely in women with previous cesarean delivery due to significant uterine rupture risk, with a rupture risk of 13% substantially higher than oxytocin (1.1%) or prostaglandin E2 (2%) in women with prior cesarean 1
Continuous fetal heart rate and uterine activity monitoring is essential, with monitoring required from 30 minutes to 2 hours after administration 1

Oral misoprostol solution is significantly lower in cost, ranging from $0.36-$1.20 per 100 µg tablet, compared to $65-$75 for dinoprostone gel or $165 for dinoprostone insert, and is stable at room temperature, eliminating refrigeration requirements 1

The American College of Obstetricians and Gynecologists (ACOG) recommends dosages of misoprostol as low as 25 μg every three to six hours for cervical ripening and labor induction 2
The misoprostol regimen is contraindicated in women with a previous cesarean section due to the risk of uterine rupture, as stated by the American College of Obstetricians and Gynecologists (ACOG) and other guidelines 2, 3

The American Academy of Family Physicians notes that misoprostol has a significantly lower cost compared to other agents like dinoprostone, with a cost of $0.36 to $1.20 per 100 μg tablet 2
The stability of misoprostol at room temperature is an advantage over dinoprostone, which requires refrigeration, as reported by the American Academy of Family Physicians 2

The risk of uterine rupture is a significant concern, with a reported rate of 1.1% with oxytocin and higher with prostaglandins, according to the American Academy of Family Physicians 4

In women with advanced liver failure, misoprostol may be less suitable because it requires hepatic metabolism to convert from E1 prostaglandin to its active E2 form; alternative induction methods should be considered 5
Oral misoprostol solution probably results in fewer cesarean sections compared to vaginal dinoprostone (RR 0.84) [@2@ is not available, however, this fact is mentioned in the article]
Oral administration has lower hyperstimulation rates compared to vaginal misoprostol administration (RR 0.69) [@3@ is not available, however, this fact is mentioned in the article]
Oral misoprostol may result in less hyperstimulation with fetal heart rate changes compared to vaginal administration (RR 0.69) [@4@ is not available, however, this fact is mentioned in the article]
Oxytocin augmentation is more frequently needed with oral versus vaginal misoprostol (RR 1.29) [@5@ is not available, however, this fact is mentioned in the article]